Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow, this PR is, well, exactly what I'd expect. More blowhard bullsh!t. He needs a new template. Just give it a few months, it'll be the shareholders fault again for the failure to capitalize on this bullsh!t PR.
SMH
Lol, trying this one again eh? Lol
That's great, how bout that balance sheet? I can see why one would shy away from the question.
And therein lies the problem...
Seems to me this is a DECN problem as Berman and shills take great interest in message boards, which is truly sad.
Nice day today, things must be on the up n up...don't ask me, just read the PR's. They are always true...
Seems more knowledgeable than everyone that's posted today. Yes, everyone.
Still SPAM.
Look at his history, touting articles from same outlet you need to register for. SPAM.
woof woof
Over 2 million dollar net loss in this seminal year. Hate to see what a normal year looks like...
Thanks
Speaking of faux, name one thing you've predicted that has come true. Name one press release that has been realized. Just one of each, that's all.
Sounds to me like someone's a bit envious of IP.
Anybody remember this?
Deja Vu all over again...
Wednesday, November 30, 2016 9:20 AM
Company Receives International Orders for Over 3 Million Units in the Next 13 Months, Immediately Raises Monthly Factory Output to 620,000 Units
LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service, and regulatory processes agent for GenStripâ„¢ 50 and the GenUltimate!â„¢ glucose test strips, both designed to work with the market leading Johnson & Johnson's ("J&J") LifeScan OneTouch Ultra family of glucose testing meters, and the in-development GenSure!â„¢ and GenChoice!â„¢ glucose test strips targeted to the U.S. and/or developing world markets today conveys recent marketing plan advancements and new international distributor additions.
Since the landmark conclusion of the successful litigation defense to the imaginary patent infringement allegations filed by J&J, the company has focused its energies and resources towards the precise execution of its formal marketing plan. Several recent communications to its shareholders and the broader investment community were highlighted by the pursuit and completion of the initial phase of that Plan. Hundreds of on-line retail merchandising venues had been added and through which Gen family of test strip revenue had begun flowing. That successful tactical campaign continues to increase distribution point locations and expand individual location footprint. In anticipation of this accelerated demand, factory capacity has been increased by the Pennsylvania and the South Korea contract manufacturers to 620,000 GenUltimate! units per month.
Concurrent to that on-line escalation, the company initiated the second chapter of its detailed Plan with the targeting and contracting of a global network of international distributors. That network remains in development and its conclusion is not shortly expected, however, initial progress has yielded short term positive accomplishments; two of which the company would like to share with its loyal shareholders:
Uni-Care Corp
Seoul, South Korea
Macre Diagnosis S.R.L.
Santa Cruz, Bolivia
Both of these newly added international distributors will represent the company's GenUltimate!, GenSure! and GenChoice! product line in multiple nations. The agreement requires that each distributor maintain a local sub-distributor in each individual nation within their territorial exclusive.
Keith Berman, PEO of Decision Diagnostics commented, "It is gratifying and highly appropriate that immediately following the Thanksgiving holiday we are in a position to update our shareholders and the entire investment community regarding the continuation of our efforts to execute our marketing plan, and to communicate the initial fruits of those tactical endeavors. We are all thankful for the loyalty of our investors and the support of our customers."
The Company has contracted Uni-Care Corp to exclusively distribute the Gen family of test strips to the Republic of South Korea, China and the Philippines. Uni-Care has activated the arrangement with the submission of an initial stocking purchase order for approximately 40,000 pieces of GenUltimate! test strips to be shipped immediately following the product's registration with South Korea's KFDA regulatory agency, expected in early December. Additional stocking orders are expected from sub-distributors in China and the Philippines. The Uni-Care Exclusive Distribution Agreement requires the annual purchase of a minimum of 250,000 GenUltimate! units in the next 12 months.
Macre Diagnostics S.R.L. has become the company's distributor to multiple countries in South America. Macre, located in Santa Cruz, Bolivia has secured its regulatory approvals and has placed an initial opening order for 10,800 pieces of GenUltimate! with a 12 month cumulative order for 2,850,000 pieces of GenUltimate!
Mr. Berman continued, "Five years ago we committed to defeating J&J in the courts, regardless of the cost, in order to recapture our right to manufacture and sell our superior line of blood glucose test strips anywhere and to anyone without fear of interference or reprisal. That battle has ended and we were overwhelmingly victorious. We are now well into our new campaign targeting the global markets that supply the diabetic test strip to their ever-growing diabetic populations. The two newly contracted international distributor accounts that we have recently added to our network, and about which we are now communicating, is an impressive beginning. Our investors can expect to hear more similar conquests as we proceed into 2017."
Forward-Looking Statements:
This release contains the Company's forward-looking statements which are based on management's current expectations and assumptions as of November 29, 2016, regarding the Company's business and performance, its prospects, current factors, the economy and other future conditions and forecasts of future events, circumstances and results.
CONTACT INFORMATION
Decision Diagnostics Corp.
Keith Berman
(805) 446-2973
info@decisiondiagnostics.com
www.genultimate.com
www.decisiondiagnostics.com
SOURCE: Decision Diagnostics Corp.
Lol, and who's your mark???
lol, what a silly statement. It's always some big conspiracy isn't it.
lol, that's what I thought, you are turning this away from simple facts. List one that isn't fact, how about that?
Wow nice day today, I dont know how ppl still defend this P.O.S.
Youguys should exchange numbers and spare us all the childish antics and stupidity.
A big steaming pile of dogsh!t that's about to get the rug pulled out from under them by JnJ. The carrots are hard to come by these days for KB. Hence all the board chatter...
Don't know why one needs credentials, it's an opinion formulated by someone with working eyeballs. Can't say I disagree with it either...
30% spread, nobody buying above .021 right now.
he is a pos....burn mf, burn!
That's just dumb. Control yourself.
lol, I disagree, seems they have plenty of time for that, everyday, and that should be a red flag. Maybe that is the one thing. Good call.
It isn't all about stock price with him.
Then what is it? Certainly this company must be good at something? What is that one thing?
Why would a non-shareholder care about that?
Being a non-shareholder yourself you should be able to answer that.
Bermans mortgage, car payments and vacations. PROVE TO ME ITS NOT KEITH! There, I saved you the time.
Why would someone from New York have an IP that would tell their computer to ship to the Walmart in Westlake Village? lol
GenUltimate
Walmart # 568919393
$16.39
Free 2-day shipping on orders over $35
Arrives by Sat, Sep 22
Free pickup Tue, Sep 25
Ships to Thousand Oaks, 512 North Ventu Park Road
Wow another solid day I see.
A company such as DECN should not hype falsities to sell shares.
More so than not unfortunately, that's what happens here. I'll never forget august of 2016 when berman asked me to call him, I did and he asked me to leak info onto the board. I refused. The funny thing is, I'm not the only one that's happened to...
We know Berman uses some of the money for those. What does he use the rest for?